Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

The implementation of academic detailing and its effectiveness on appropriate prescribing of pain relief medication: a real-world cluster randomized trial in Belgian general practices.

Bruyndonckx R, Verhoeven V, Anthierens S, Cornelis K, Ackaert K, Gielen B, Coenen S.

Implement Sci. 2018 Jan 10;13(1):6. doi: 10.1186/s13012-017-0703-8.

2.

Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial.

Goossens ME, Zeegers MP, van Poppel H, Joniau S, Ackaert K, Ameye F, Billiet I, Braeckman J, Breugelmans A, Darras J, Dilen K, Goeman L, Tombal B, Van Bruwaene S, Van Cleyenbreugel B, Van der Aa F, Vekemans K, Buntinx F.

Eur J Cancer. 2016 Dec;69:9-18. doi: 10.1016/j.ejca.2016.09.021. Epub 2016 Oct 29.

PMID:
27814472
3.

Total hip arthroplasty in Belgium: the contribution of a social health insurer to the debate.

De Bethune X, Ackaert K, Gillet P, Van Dooren J.

Acta Orthop Belg. 2014 Sep;80(3):348-56.

PMID:
26280608
4.

Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial.

van Kerrebroeck P, Chapple C, Drogendijk T, Klaver M, Sokol R, Speakman M, Traudtner K, Drake MJ; NEPTUNE Study Group.

Eur Urol. 2013 Dec;64(6):1003-12. doi: 10.1016/j.eururo.2013.07.034. Epub 2013 Aug 3.

5.

Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium.

Goossens ME, Buntinx F, Joniau S, Ackaert K, Ameye F, Billiet I, Braeckman J, Breugelmans A, Darras J, Dilen K, Goeman L, Kellen E, Tombal B, Van Bruwaene S, Van Cleyenbreuge B, Van der Aa F, Vekemans K, Van Poppel H, Zeegers MP.

BMC Urol. 2012 Mar 21;12:8. doi: 10.1186/1471-2490-12-8.

6.

Effect of dutasteride on the risk of prostate cancer.

Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group.

N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127.

7.
8.

[Hormone therapy before radical prostatectomy. Effects on surgical method and resection margins. Belgian Uro-Oncological Study Group (B.U.O.S.)].

De Ridder D, Elgamal A, Werbrouck P, Ackaert K, Van Poppel H, Van de Voorde W, Oyen R, Baert L.

Acta Urol Belg. 1994 Apr;62(1):61-5. French.

PMID:
8197931
9.

Treatment of distal ureteral stones in the horse riding position.

Ackaert KS, Dik P, Lock MT, Kurth KH, Schröder FH.

J Urol. 1989 Oct;142(4):955-7.

PMID:
2795750
10.

Long-term results of extracorporeal shock wave lithotripsy in children.

Nijman RJ, Ackaert K, Scholtmeijer RJ, Lock TW, Schröder FH.

J Urol. 1989 Aug;142(2 Pt 2):609-11; discussion 619.

PMID:
2746787
11.

[Experiences with extracorporeal shockwave lithotripsy in 61 children].

Lock MT, Speelman A, Nijman JM, Ackaert KS, Dik P, Scholtmeijer RJ.

Ned Tijdschr Geneeskd. 1989 Apr 1;133(13):669-72. Dutch.

PMID:
2654657
12.

Risk factors in outpatient extracorporeal shock wave lithotripsy.

Ackaert KS, Hop WC, Heemskerk CA, Schröder FH.

Eur Urol. 1989;16(5):349-53.

PMID:
2776805
13.

Effects of extracorporeal shock wave lithotripsy (ESWL) on renal tissue. A review.

Ackaert KS, Schröder FH.

Urol Res. 1989;17(1):3-7. Review. No abstract available.

PMID:
2646808

Supplemental Content

Loading ...
Support Center